– Maintains Minority Equity Stake in Ciitizen – – Anticipated Total Cash Savings of Approximately $90-100 Million on an Annualized Basis – SAN FRANCISCO, Dec. 13, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced strategic changes to streamline operations and reduce operating cash burn. The company has divested the assets of Ciitizen and… Continue reading Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts
Category: Newswire
BENCHMARK ELECTRONICS ANNOUNCES QUARTERLY CASH DIVIDEND
Fourth quarter 2023 cash dividend of $0.165 per share TEMPE, Ariz., Dec. 13, 2023 /PRNewswire/ — Benchmark Electronics, Inc. (NYSE: BHE) today announced that its Board of Directors declared a quarterly dividend of $0.165 per share, payable on January 12, 2024, to shareholders of record at the close of business on December 29, 2023. About… Continue reading BENCHMARK ELECTRONICS ANNOUNCES QUARTERLY CASH DIVIDEND
NRx Pharmaceuticals Provides Notice of Annual Meeting of Shareholders
RADNOR, Pa., Dec. 13, 2023 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, announced their 2023 Annual Meeting of Stockholders (the “Annual Meeting”) to be held on December 19, 2023, at 11:00 a.m., Eastern Time, in virtual-only format at https://www.cstproxy.com/nrxpharma/am2023. Management will discuss the items detailed in the Proxy Statement,… Continue reading NRx Pharmaceuticals Provides Notice of Annual Meeting of Shareholders
Scholastic Corporation Announces Third Quarter Dividend
NEW YORK, Dec. 13, 2023 /PRNewswire/ — Scholastic Corporation (NASDAQ: SCHL) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on the Company’s Class A and Common Stock for the third quarter of fiscal 2024. The dividend is payable on March 15, 2024, to all shareholders of record… Continue reading Scholastic Corporation Announces Third Quarter Dividend
AGNC Investment Corp. Declares Fourth Quarter Dividends on Preferred Stock
BETHESDA, Md., Dec. 13, 2023 /PRNewswire/ — AGNC Investment Corp. (Nasdaq: AGNC) (“AGNC” or the “Company”) announced today that its Board of Directors has declared cash dividends on the outstanding depositary shares1 of the following series of preferred stock for the fourth quarter 2023: Series of Preferred Stock Ticker Per Annum Dividend Rate Dividend Per… Continue reading AGNC Investment Corp. Declares Fourth Quarter Dividends on Preferred Stock
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for December 2023
BETHESDA, Md., Dec. 13, 2023 /PRNewswire/ — AGNC Investment Corp. (Nasdaq: AGNC) announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for December 2023. The dividend is payable on January 10, 2024 to common stockholders of record as of December 29, 2023. For further information… Continue reading AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for December 2023
MARPAI, INC. ANNOUNCES APPOINTMENT OF TWO NEW INDEPENDENT DIRECTORS
NEW YORK, Dec. 13, 2023 /PRNewswire/ — Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), an independent national Third-Party Administrator (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans, today announced the addition of two new members to its Board of Directors (the “Board”) as part of the Company’s ongoing transformation plan and commitment… Continue reading MARPAI, INC. ANNOUNCES APPOINTMENT OF TWO NEW INDEPENDENT DIRECTORS
FDA Grants Priority Review to Amgen’s Tarlatamab Application for Advanced Small Cell Lung Cancer
Currently There are no Approved Therapeutic Options for Third-Line Treatment of Advanced SCLC1 If Approved, Tarlatamab Would be the First BiTE® Therapy for a Major Solid Tumor FDA Target Action Date is June 12, 2024 THOUSAND OAKS, Calif., Dec. 13, 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA)… Continue reading FDA Grants Priority Review to Amgen’s Tarlatamab Application for Advanced Small Cell Lung Cancer
37% of consumers will spend months paying off holiday season debts, Achieve survey finds
While most Americans prioritize using money on hand to pay for holiday expenses and being budget conscious, half will still take on debt this season SAN MATEO, Calif., Dec. 13, 2023 /PRNewswire/ — Half of American consumers expect to take on debt to pay for the holidays, including 37% who believe it will take them… Continue reading 37% of consumers will spend months paying off holiday season debts, Achieve survey finds
Rising Vehicle and Tire Demand Propels Tire Storage Rack Market to US$ 1,218.10 Million by 2034 | Future Market Insights, Inc.
Booming vehicle production, evolving safety regulations, and changing consumer preferences are fueling the tire rack storage market. Advanced technology like RFID tracking is further driving demand for efficient and innovative storage solutions. NEWARK, Del., Dec. 13, 2023 /PRNewswire/ — The tire storage rack market is estimated to be worth US$ 871.9 million in 2024 and is… Continue reading Rising Vehicle and Tire Demand Propels Tire Storage Rack Market to US$ 1,218.10 Million by 2034 | Future Market Insights, Inc.